ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ROUSELINE VALENTIN TORRES M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,285Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 551

$391K Total Retail Price of All Prescriptions

Rank: 145 out of 551

322 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 322 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 10,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$29 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 761 655 1 1
GABAPENTIN 726 543 2 3
ENALAPRIL MALEATE 630 551 3 5
PRAVASTATIN SODIUM 546 438 4 24
RANITIDINE HCL 517 404 5 8
ATENOLOL 437 374 6 12
OMEPRAZOLE 428 338 7 7
METFORMIN HCL 394 322 8 2
LEVOTHYROXINE SODIUM 335 291 9 9
ASPIRIN EC 329 276 10 26
LOSARTAN POTASSIUM 306 247 11 6
AMLODIPINE BESYLATE 295 251 12 4
LOSARTAN-HYDROCHLOROTHIAZIDE 286 234 13 10
DOXAZOSIN MESYLATE 260 224 14 25
GLIMEPIRIDE 246 197 15 16
ISOSORBIDE MONONITRATE ER 227 203 16 21
CARVEDILOL 217 179 17 22
TRAMADOL HCL 196 116 18 32
ENALAPRIL-HYDROCHLOROTHIAZIDE 190 168 19 131
FUROSEMIDE 156 110 20 13
TRAMADOL HCL-ACETAMINOPHEN 149 130 21 18
LISINOPRIL 141 127 22 14
METOPROLOL TARTRATE 141 118 22 17
HUMULIN 70-30 138 122 24 35
MECLIZINE HCL 136 134 25 56
GLIPIZIDE XL 133 120 26 81
FENOFIBRATE 113 81 27 34
PAROXETINE HCL 113 102 27 77
SYNTHROID 109 81 29 11
HYDROCHLOROTHIAZIDE 108 80 30 15
AMITRIPTYLINE HCL 102 74 R 31 96
CIPROFLOXACIN HCL 99 81 32 54
EVISTA 84 72 33 52
INSULIN SYRINGE 84 60 33 41
CLOPIDOGREL 84 70 33 30
PLAVIX 83 76 36 33
PANTOPRAZOLE SODIUM 83 78 36 36
ZOLPIDEM TARTRATE 81 62 38 27
INDAPAMIDE 80 76 39 116
FAMOTIDINE 80 73 39 31
METOPROLOL SUCCINATE 70 55 41 23
CARBIDOPA-LEVODOPA 70 60 41 188
CRESTOR 70 39 41 62
HUMULIN N 69 51 44 47
MAXIMUM D3 69 64 44 103
NAPROXEN 68 55 46 80
LANSOPRAZOLE 68 49 46 72
LEVOXYL 66 54 48 40
CHLORTHALIDONE 65 39 49 165
METOCLOPRAMIDE HCL 65 52 49 107
ETODOLAC 65 57 49 95
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 42 52 112
QUINAPRIL HCL 62 54 53 104
TAMSULOSIN HCL 61 54 54 38
ACTOS 55 43 55 135
CAPTOPRIL 55 36 55 63
ALENDRONATE SODIUM 54 49 57 19
GLIPIZIDE 54 45 57 20
TERAZOSIN HCL 53 53 59 128
SULINDAC 52 48 60 78
FOSINOPRIL SODIUM 52 52 60 89
JANUVIA 51 39 62 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.